Beximco Pharma: FY2019 results register double-digit revenue growth | Motif Bio (MTFB.L): Settlement with clinical research organisation | Evgen Pharma plc (EVG.L): SFX-01 fails in stroke study | Open Orphan (ORPH.L): Venn Life Sciences strikes partner agreement
11 Nov 2019
SP Angel Healthcare Conditions
Sign up to access
Get access to our full offering from over 30 providers
Get access to our full offering from over 30 providers
SP Angel Healthcare Conditions
Beximco Pharmaceuticals Limited Sponsored GDR RegS (BXP:LON), 37.0 | Evgen Pharma Plc (EVG:LON), 0.8 | hVIVO plc (HVO:LON), 26.5
- Published:
11 Nov 2019 -
Author:
Vadim Alexandre | Liam Gascoigne-Cohen -
Pages:
4
Beximco Pharma: FY2019 results register double-digit revenue growth | Motif Bio (MTFB.L): Settlement with clinical research organisation | Evgen Pharma plc (EVG.L): SFX-01 fails in stroke study | Open Orphan (ORPH.L): Venn Life Sciences strikes partner agreement